Roche Inks RNA-Targeted Small Molecule Pact With Ribometrix

 
• By Joseph Haas

Deal snapshot: Roche’s third partnership around small molecule, RNA-targeted therapies taps Ribometrix’s three-dimensional structural analysis of RNA to find pockets amenable to small molecule drugs.

Business partners hands on top of each other symbolizing companionship
Deal with Ribometrix is third for Roche in RNA-targeting small molecule R&D

More from Deals

More from Business